vs
PROVIDENT FINANCIAL HOLDINGS INC(PROV)与TriSalus Life Sciences, Inc.(TLSI)财务数据对比。点击上方公司名可切换其他公司
TriSalus Life Sciences, Inc.的季度营收约是PROVIDENT FINANCIAL HOLDINGS INC的1.3倍($13.2M vs $9.8M),PROVIDENT FINANCIAL HOLDINGS INC净利率更高(14.6% vs -73.9%,领先88.5%),TriSalus Life Sciences, Inc.同比增速更快(59.8% vs 2.5%),PROVIDENT FINANCIAL HOLDINGS INC自由现金流更多($1.0M vs $-2.5M),过去两年TriSalus Life Sciences, Inc.的营收复合增速更高(43.0% vs 2.3%)
普罗维登特金融控股公司是一家银行控股企业,通过旗下全资子公司普罗维登特储蓄银行开展业务,为美国加利福尼亚州当地社区提供各类存款、住房抵押贷款、消费贷款、小微企业融资等零售及商业金融服务。
TriSalus生命科学公司是一家临床阶段生物技术企业,专注于免疫肿瘤学与介入肿瘤学领域,研发专有的靶向给药技术,用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果,主要在北美市场开展临床合作及业务运营。
PROV vs TLSI — 直观对比
营收规模更大
TLSI
是对方的1.3倍
$9.8M
营收增速更快
TLSI
高出57.4%
2.5%
净利率更高
PROV
高出88.5%
-73.9%
自由现金流更多
PROV
多$3.6M
$-2.5M
两年增速更快
TLSI
近两年复合增速
2.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $9.8M | $13.2M |
| 净利润 | $1.4M | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | 20.8% | -24.8% |
| 净利率 | 14.6% | -73.9% |
| 营收同比 | 2.5% | 59.8% |
| 净利润同比 | 64.7% | 3.5% |
| 每股收益(稀释后) | $0.22 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PROV
TLSI
| Q4 25 | $9.8M | $13.2M | ||
| Q3 25 | $9.7M | $11.6M | ||
| Q2 25 | $9.8M | $11.2M | ||
| Q1 25 | $10.1M | $9.2M | ||
| Q4 24 | $9.6M | $8.3M | ||
| Q3 24 | $9.5M | $7.3M | ||
| Q2 24 | $9.9M | $7.4M | ||
| Q1 24 | $9.4M | $6.5M |
净利润
PROV
TLSI
| Q4 25 | $1.4M | $-9.8M | ||
| Q3 25 | $1.7M | $-10.8M | ||
| Q2 25 | $1.6M | $-8.3M | ||
| Q1 25 | $1.9M | $-10.4M | ||
| Q4 24 | $872.0K | $-10.1M | ||
| Q3 24 | $1.9M | $-2.4M | ||
| Q2 24 | $2.0M | $-4.3M | ||
| Q1 24 | $1.5M | $-13.2M |
毛利率
PROV
TLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率
PROV
TLSI
| Q4 25 | 20.8% | -24.8% | ||
| Q3 25 | 28.1% | -77.9% | ||
| Q2 25 | 23.6% | -65.4% | ||
| Q1 25 | 26.2% | -79.9% | ||
| Q4 24 | 12.7% | -91.8% | ||
| Q3 24 | 28.3% | -118.9% | ||
| Q2 24 | 27.8% | -111.0% | ||
| Q1 24 | 22.5% | -180.8% |
净利率
PROV
TLSI
| Q4 25 | 14.6% | -73.9% | ||
| Q3 25 | 17.3% | -93.5% | ||
| Q2 25 | 16.7% | -73.9% | ||
| Q1 25 | 18.4% | -113.2% | ||
| Q4 24 | 9.1% | -122.4% | ||
| Q3 24 | 20.0% | -32.6% | ||
| Q2 24 | 19.7% | -58.8% | ||
| Q1 24 | 15.9% | -204.5% |
每股收益(稀释后)
PROV
TLSI
| Q4 25 | $0.22 | $-0.22 | ||
| Q3 25 | $0.25 | $-0.96 | ||
| Q2 25 | $0.24 | $-0.27 | ||
| Q1 25 | $0.28 | $-0.39 | ||
| Q4 24 | $0.13 | $-0.38 | ||
| Q3 24 | $0.28 | $-0.12 | ||
| Q2 24 | $0.28 | $-0.21 | ||
| Q1 24 | $0.22 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $54.4M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $127.5M | $-33.9M |
| 总资产 | $1.2B | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
PROV
TLSI
| Q4 25 | $54.4M | $20.4M | ||
| Q3 25 | $49.4M | $22.7M | ||
| Q2 25 | $53.1M | $26.5M | ||
| Q1 25 | $50.9M | $13.0M | ||
| Q4 24 | $45.5M | $8.5M | ||
| Q3 24 | $48.2M | $11.3M | ||
| Q2 24 | $51.4M | $16.5M | ||
| Q1 24 | $51.7M | $4.0M |
股东权益
PROV
TLSI
| Q4 25 | $127.5M | $-33.9M | ||
| Q3 25 | $128.4M | $-26.7M | ||
| Q2 25 | $128.5M | $-19.4M | ||
| Q1 25 | $128.9M | $-34.4M | ||
| Q4 24 | $128.6M | $-25.9M | ||
| Q3 24 | $129.6M | $-20.4M | ||
| Q2 24 | $129.9M | $-25.3M | ||
| Q1 24 | $129.5M | $-36.0M |
总资产
PROV
TLSI
| Q4 25 | $1.2B | $35.3M | ||
| Q3 25 | $1.2B | $36.5M | ||
| Q2 25 | $1.2B | $41.3M | ||
| Q1 25 | $1.3B | $28.6M | ||
| Q4 24 | $1.3B | $24.0M | ||
| Q3 24 | $1.3B | $27.5M | ||
| Q2 24 | $1.3B | $32.4M | ||
| Q1 24 | $1.3B | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $1.2M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $1.0M | $-2.5M |
| 自由现金流率自由现金流/营收 | 10.5% | -19.1% |
| 资本支出强度资本支出/营收 | 1.9% | 0.3% |
| 现金转化率经营现金流/净利润 | 0.85× | — |
| 过去12个月自由现金流最近4个季度 | $14.9M | $-19.1M |
8季度趋势,按日历期对齐
经营现金流
PROV
TLSI
| Q4 25 | $1.2M | $-2.5M | ||
| Q3 25 | $2.5M | $-3.7M | ||
| Q2 25 | $8.7M | $-7.3M | ||
| Q1 25 | $3.3M | $-4.5M | ||
| Q4 24 | $324.0K | $-5.7M | ||
| Q3 24 | $2.6M | $-10.8M | ||
| Q2 24 | $5.7M | $-13.4M | ||
| Q1 24 | $3.0M | $-10.9M |
自由现金流
PROV
TLSI
| Q4 25 | $1.0M | $-2.5M | ||
| Q3 25 | $2.5M | $-3.9M | ||
| Q2 25 | $8.2M | $-7.4M | ||
| Q1 25 | $3.3M | $-5.3M | ||
| Q4 24 | $307.0K | $-5.8M | ||
| Q3 24 | $2.4M | $-11.0M | ||
| Q2 24 | $4.1M | $-13.5M | ||
| Q1 24 | $2.6M | $-10.9M |
自由现金流率
PROV
TLSI
| Q4 25 | 10.5% | -19.1% | ||
| Q3 25 | 25.2% | -33.9% | ||
| Q2 25 | 83.5% | -66.1% | ||
| Q1 25 | 32.5% | -57.3% | ||
| Q4 24 | 3.2% | -69.7% | ||
| Q3 24 | 25.1% | -149.9% | ||
| Q2 24 | 41.3% | -183.1% | ||
| Q1 24 | 27.5% | -169.3% |
资本支出强度
PROV
TLSI
| Q4 25 | 1.9% | 0.3% | ||
| Q3 25 | 0.5% | 1.9% | ||
| Q2 25 | 5.4% | 0.8% | ||
| Q1 25 | 0.3% | 8.2% | ||
| Q4 24 | 0.2% | 0.6% | ||
| Q3 24 | 1.8% | 2.3% | ||
| Q2 24 | 16.0% | 0.8% | ||
| Q1 24 | 4.2% | 1.0% |
现金转化率
PROV
TLSI
| Q4 25 | 0.85× | — | ||
| Q3 25 | 1.48× | — | ||
| Q2 25 | 5.34× | — | ||
| Q1 25 | 1.79× | — | ||
| Q4 24 | 0.37× | — | ||
| Q3 24 | 1.35× | — | ||
| Q2 24 | 2.91× | — | ||
| Q1 24 | 2.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图